Skip to main content
返回讨论

生物制药行业与社会

Healthcare
United States
开始于 April 22, 2026

The Bio-Pharma Industry and Society Listing Summary Please join the CSIS Global Health Policy Center on March 17, from 10:00am – 11:30am, for an exploration of how private bio-pharmaceutical firms can better support the critically important societal goals of improved affordability, access, quality, and innovation. Drupal Admin Thu, 03/03/2016 - 15:36 Featured Image Image Contributors J. Stephen Morrison Downloads Download Transcript Here Document 160317_The_Bio-Pharma_Industry_and_Society_Tra...

来源文章

The Bio-Pharma Industry and Society

CSIS (United States) | Mar 03, 2016

添加陈述 分析 0/5
Need to find a specific claim? Search all statements.
🗳️ Join the conversation
5 条陈述待投票 • Your perspective shapes the analysis
📊 Progress to Consensus Analysis Need: 7+ participants, 20+ votes, 3+ votes per statement
Participants 0/7
Statements (7+ recommended) 5/7
Total Votes 0/20
💡 Progress updates live here. Final readiness is confirmed when all three requirements are met.

Your votes count

No account needed — your votes are saved and included in the consensus analysis. Create an account to track your voting history and add statements.

CLAIM 发布者 will • Apr 22, 2026
生物制药行业必须优先考虑可负担性和可及性，确保救命药物对所有人都可获得，而不仅仅是富人。
AI 翻译 · 显示原文

The bio-pharma industry must prioritize affordability and access to ensure that life-saving medications are available to all, not just the wealthy.

Vote options for this statement: agree, disagree, or unsure
💬 查看讨论
Be first to respond
Vote to see results
CLAIM 发布者 will • Apr 22, 2026
虽然创新至关重要，但生物制药行业无情的利润追求往往导致药物价格虚高，损害公共健康。
AI 翻译 · 显示原文

While innovation is crucial, the relentless pursuit of profit in the bio-pharma sector often leads to inflated drug prices, undermining public health.

Vote options for this statement: agree, disagree, or unsure
💬 查看讨论
Be first to respond
Vote to see results
CLAIM 发布者 will • Apr 22, 2026
生物制药行业对快速创新的关注可能会损害药物的质量和安全性，对患者构成风险。
AI 翻译 · 显示原文

The focus on rapid innovation in the bio-pharma industry can compromise the quality and safety of medications, posing risks to patients.

Vote options for this statement: agree, disagree, or unsure
💬 查看讨论
Be first to respond
Vote to see results
CLAIM 发布者 will • Apr 22, 2026
生物制药领域的公私合作可以加强研究和开发，带来造福整个社会的突破。
AI 翻译 · 显示原文

Public-private partnerships in the bio-pharma sector can enhance research and development, leading to breakthroughs that benefit society as a whole.

Vote options for this statement: agree, disagree, or unsure
💬 查看讨论
Be first to respond
Vote to see results
CLAIM 发布者 will • Apr 22, 2026
需要采取平衡的方法；生物制药行业可以推动创新，同时也要解决可及性和可负担性问题。
AI 翻译 · 显示原文

A balanced approach is necessary; the bio-pharma industry can drive innovation while also addressing issues of access and affordability.

Vote options for this statement: agree, disagree, or unsure
💬 查看讨论
Be first to respond
Vote to see results

💡 How This Works

  • • Add Statements: Post claims or questions (10-500 characters)
  • • Vote: Agree, Disagree, or Unsure on each statement
  • • Respond: Add detailed pro/con responses with evidence
  • • Consensus: After enough participation, analysis reveals opinion groups and areas of agreement

Society Speaks is open and independent. Your support keeps civic discussion free from advertising and commercial influence.

Support us